AMNEAL PHARMACEUTICALS, INC. (AMRX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $545.58M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-100.67M; Retained Earnings (Accumulated Deficit)USD $-415.09M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $536.30M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-112.15M; Retained Earnings (Accumulated Deficit)USD $-472.75M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $571.79M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-110.73M; Retained Earnings (Accumulated Deficit)USD $-535.00M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Additional Paid in CapitalUSD $563.36M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-105.88M; Retained Earnings (Accumulated Deficit)USD $-570.08M.
AMNEAL PHARMACEUTICALS, INC. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD | Reclassification from Accumulated Other Comprehensive Income, Current Period, Net of Tax USD | Common Stock, Value, Issued USD | Noncontrolling Interest, Increase from Subsidiary Equity Issuance USD | Noncontrolling Interest, Increase from Business Combination USD | Partners' Capital Account, Contributions USD | Partners' Capital Account, Unit-based Payment Arrangement, Amount USD | Partners' Capital Account, Return of Capital USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $545.58M | $-100.67M | $-415.09M | $33.02M | $33.02M | 3 month · $10.39M 6 month · $19.21M | (m) | 6 month · $-5.79M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $536.30M | $-112.15M | $-472.75M | $-45.41M | $-45.97M | 3 month · $8.82M | (m) | 3 month · $-2.88M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $571.79M | $-110.73M | $-535.00M | $-70.79M | $-71.33M | 12 month · $31.95M | (m) | 12 month · $-1.23M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $563.36M | $-105.88M | $-570.08M | $-109.46M | $-109.95M | 3 month · $8.22M 9 month · $23.75M | (m) | 9 month · $1.71M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $554.62M | $-97.43M | $-572.45M | $-112.12M | $-112.53M | 3 month · $8.27M 6 month · $15.53M | (m) | 6 month · $5.88M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $545.81M | $-85.74M | $-594.87M | $-131.67M | $-132.00M | 3 month · $7.26M | (m) | 3 month · $6.44M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $560.21M | $-65.51M | $-607.06M | $-109.27M | $-109.51M | 12 month · $27.77M | (m) | 12 month · $26.20M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $553.23M | $-73.78M | $-575.98M | $-93.43M | $-93.57M | 3 month · $7.11M 9 month · $20.56M | (m) | 9 month · $19.62M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $545.70M | $-30.44M | $-575.83M | $-57.47M | $-57.49M | 3 month · $6.72M 6 month · $13.45M | (m) | 6 month · $13.03M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $538.72M | $-23.71M | $-581.82M | $-63.72M | $-63.63M | 3 month · $6.72M | (m) | 3 month · $6.51M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $539.24M | $-32.35M | $-490.18M | $19.78M | $20.01M | 12 month · $26.82M | (m) | 12 month · $3.37M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $715.45M | $3.87M | $-391.53M | $330.86M | $154.24M | 3 month · $6.69M 9 month · $20.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $708.23M | $8.08M | $-401.21M | $318.17M | $150.77M | 3 month · $6.56M 6 month · $14.16M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $700.72M | $3.76M | $-413.13M | $294.41M | $134.67M | 3 month · $7.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $691.63M | $9.94M | $-406.18M | $298.42M | $183.98M | 12 month · $31.85M | 12 month · $883.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | $0.00 | $683.75M | $12.54M | $-401.85M | $297.47M | $194.29M | 3 month · $7.69M 9 month · $24.02M | 9 month · $883.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $675.59M | $868.00K | $-399.16M | $280.33M | $172.99M | 3 month · $8.26M 6 month · $16.33M | 6 month · $883.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $0.00 | $666.80M | $-349.00K | $-278.35M | $391.12M | $407.41M | 3 month · $8.06M | 3 month · $883.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-12-31 | $0.00 | $658.35M | $-24.83M | $-276.20M | $360.34M | $366.97M | 12 month · $28.41M | (m) | (m) | (m) | (m) | 12 month · $2.00M | (m) | (m) | (m) |
| 2021-09-30 | $0.00 | $650.54M | $-33.23M | $-269.82M | $350.51M | $383.17M | 3 month · $7.71M 9 month · $20.67M | (m) | (m) | (m) | (m) | 9 month · $2.00M | (m) | (m) | (m) |
| 2021-06-30 | $0.00 | $642.66M | $-33.98M | $-265.58M | $346.11M | $390.27M | 3 month · $7.63M 6 month · $12.96M | (m) | (m) | (m) | (m) | 3 month · $2.00M 6 month · $2.00M | (m) | (m) | (m) |
| 2021-03-31 | $0.00 | $634.48M | $-34.36M | $-280.12M | $323.01M | $366.71M | 3 month · $5.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-12-31 | $0.00 | $628.41M | $-41.32M | $-286.82M | $303.27M | $344.93M | 12 month · $20.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-09-30 | $0.00 | $623.13M | $-41.31M | $-283.78M | $301.04M | $348.20M | 3 month · $5.42M 9 month · $15.62M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-06-30 | $0.00 | $617.50M | $-39.70M | $-274.81M | $306.00M | $371.02M | 3 month · $5.66M 6 month · $10.20M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2020-03-31 | $0.00 | $611.60M | $-33.41M | $-262.81M | $318.38M | $403.46M | 3 month · $4.54M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | $0.00 | $606.97M | $-68.00K | $-377.88M | $232.01M | $346.79M | 12 month · $21.68M | (m) | 12 month · $1.46M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-09-30 | $0.00 | $565.64M | $-4.88M | $-345.75M | $218.00M | $395.72M | 3 month · $6.09M 9 month · $16.67M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-06-30 | $0.00 | $544.16M | $-6.75M | $-80.75M | $459.66M | $749.35M | 3 month · $6.22M 6 month · $10.57M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-03-31 | $0.00 | $537.16M | $-4.10M | $-63.84M | $472.20M | $799.78M | 3 month · $4.35M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $0.00 | $530.44M | $-7.75M | $-20.92M | $504.75M | $896.36M | 8 month · $8.84M | 8 month · $11.71M | (m) | (m) | (m) | 8 month · $2.52M | (m) | (m) | (m) |
| 2018-09-30 | $0.00 | $520.16M | $-9.89M | $-12.15M | $501.11M | $915.32M | 5 month · $5.23M | 5 month · $11.71M | (m) | (m) | (m) | 5 month · $2.52M | (m) | (m) | (m) |
| 2018-06-30 | $0.00 | $517.12M | $-6.50M | $-19.10M | $494.50M | $939.49M | 2 month · $1.64M | 2 month · $11.86M | (m) | (m) | (m) | 2 month · $3.05M | (m) | (m) | (m) |
| 2018-05-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 4 month · $360.00K | (m) | 1 month · $27.74M 4 month · $27.74M | 1 month · $158.76M 4 month · $158.76M | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | $10.00 | 3 month · $360.00K | (m) | (m) | (m) | (m) |
| 2017-12-31 | (m) | $8.56M | $-14.23M | $-382.79M | $0.00 | $0.00 | (m) | (m) | (m) | $10.00 | (m) | (m) | 12 month · $8.60M | (m) | (m) |
| 2017-10-04 | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $43.00K |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |